Paper33767702
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.
Dhatchinamoorthy K and 2 others. Front Immunol, 2021. Cited by 863 papers, by iCite.
Cite this record
ConductScience Library. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation. Papers, record 33767702. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33767702
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigen Presentation | Major topic |
| Histocompatibility Antigens Class I | Major topic |
| Neoplasms | Major topic |
| Tumor Escape | Major topic |
| Animals | |
| Gene Deletion | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Killer Cells, Natural | |
| Lymphocytes, Tumor-Infiltrating | |
| Mutation | |
| Signal Transduction | |
| Transcription, Genetic | |
| Tumor Microenvironment |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI145932 | NIAID NIH HHS | United States | R01AI145932 | PubMed and NIH | NIH RePORTER |
| R01 CA247624 | NCI NIH HHS | United States | R01CA247624 | PubMed and NIH | NIH RePORTER |
| R01AI114495 | NIH | NIH RePORTER |
References415
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31540894 | ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome. | Cancer Immunol Res | 2019 | https://conductscience.org/library/papers/31540894 | PubMed |
| 2 | 28187290 | Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. | Cell | 2017 | https://conductscience.org/library/papers/28187290 | PubMed |
| 3 | 3259730 | Immunohistochemical analysis of tumor-infiltrating lymphocytes and major histocompatibility antigens in human gliomas and metastatic brain tumors. | Surg Neurol | 1988 | https://conductscience.org/library/papers/3259730 | PubMed |
| 4 | 28344889 | Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition. | Oncoimmunology | 2017 | https://conductscience.org/library/papers/28344889 | PubMed |
| 5 | 25781678 | The transporter associated with antigen processing: a key player in adaptive immunity. | Biol Chem | 2015 | https://conductscience.org/library/papers/25781678 | PubMed |
| 6 | 8617293 | TAP1-deficient mice select a CD8+ T cell repertoire that displays both diversity and peptide specificity. | Eur J Immunol | 1996 | https://conductscience.org/library/papers/8617293 | PubMed |
| 7 | 29301958 | A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing. | Science | 2018 | https://conductscience.org/library/papers/29301958 | PubMed |
| 8 | 31413908 | TEIPP peptides: exploration of unTAPped cancer antigens. | Oncoimmunology | 2019 | https://conductscience.org/library/papers/31413908 | PubMed |
| 9 | 19883394 | Hypermethylation of HLA class I gene is associated with HLA class I down-regulation in human gastric cancer. | Tissue Antigens | 2010 | https://conductscience.org/library/papers/19883394 | PubMed |
| 10 | 28161407 | A novel mutation in TAP1 gene leading to MHC class I deficiency: Report of two cases and review of the literature. | Clin Immunol | 2017 | https://conductscience.org/library/papers/28161407 | PubMed |
| 11 | 12738726 | Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation. | Clin Cancer Res | 2003 | https://conductscience.org/library/papers/12738726 | PubMed |
| 12 | 11970875 | Optimization of the MHC class I peptide cargo is dependent on tapasin. | Immunity | 2002 | https://conductscience.org/library/papers/11970875 | PubMed |
| 13 | 11117911 | Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. | Lancet | 2000 | https://conductscience.org/library/papers/11117911 | PubMed |
| 14 | 9421352 | Expression and prognostic significance of immunoregulatory molecules in esophageal cancer. | Int J Cancer | 1997 | https://conductscience.org/library/papers/9421352 | PubMed |
| 15 | 28331615 | Nuclear IRF-1 expression as a mechanism to assess "Capability" to express PD-L1 and response to PD-1 therapy in metastatic melanoma. | J Immunother Cancer | 2017 | https://conductscience.org/library/papers/28331615 | PubMed |
| 16 | 31358815 | Tumor intrinsic immunity related proteins may be novel tumor suppressors in some types of cancer. | Sci Rep | 2019 | https://conductscience.org/library/papers/31358815 | PubMed |
| 17 | 21436444 | Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. | Science | 2011 | https://conductscience.org/library/papers/21436444 | PubMed |
| 18 | 8198988 | Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. | Br J Cancer | 1994 | https://conductscience.org/library/papers/8198988 | PubMed |
| 19 | 3402430 | c-myc down-regulates class I HLA expression in human melanomas. | EMBO J | 1988 | https://conductscience.org/library/papers/3402430 | PubMed |
| 20 | 12747744 | Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer. | Cancer Immun | 2003 | https://conductscience.org/library/papers/12747744 | PubMed |
Cited by679
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 863 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985562 | HLA class I and II polymorphisms in pediatric neuroblastoma: mechanistic links to immune surveillance, tumor evolution, and clinical translation. | Front Genet | 2026 | https://conductscience.org/library/papers/42985562 | PubMed |
| 42982877 | Deubiquitinases at the crossroads of T-cell immunity and tumor immune evasion. | Cell Mol Immunol | 2026 | https://conductscience.org/library/papers/42982877 | PubMed |
| 42926223 | CAR-NK cell immunotherapy: a comprehensive review of engineering platforms, clinical applications in hematological and solid tumors. | J Cancer Res Clin Oncol | 2026 | https://conductscience.org/library/papers/42926223 | PubMed |
| 42909179 | Mapping programmable mRNA research relevant to cancer-associated immune escape: a dual-database bibliometric and topic modeling analysis. | Front Oncol | 2026 | https://conductscience.org/library/papers/42909179 | PubMed |
| 42903663 | Towards epigenetically informed and biobank-driven precision immunotherapy in melanoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/42903663 | PubMed |
| 42903418 | Molecular mechanisms and therapeutic strategies of immunotherapy resistance in esophageal cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42903418 | PubMed |
| 42886326 | The haunted Umwelt: a biosemiotic and hauntological account of immune semiotic corruption in field cancerization. | Theory Biosci | 2026 | https://conductscience.org/library/papers/42886326 | PubMed |
| 42882506 | Antigen-Presentation Competence in Gynecologic Cancers: Mechanisms, Evidence and Translational Priorities. | Cells | 2026 | https://conductscience.org/library/papers/42882506 | PubMed |
| 42858644 | Integrative bulk and single-cell transcriptomics identifies a HERC5-linked immune-attenuated risk program for pulmonary metastasis/relapse in osteosarcoma. | Transl Oncol | 2026 | https://conductscience.org/library/papers/42858644 | PubMed |
| 42858555 | Inhibition of cellular NEDDylation partially alters the MHC class I immunopeptidome. | J Immunol | 2026 | https://conductscience.org/library/papers/42858555 | PubMed |
| 42835524 | AXL at the nexus of therapeutic resistance, tumor vascularization, and immune evasion in cancer. | iScience | 2026 | https://conductscience.org/library/papers/42835524 | PubMed |
| 42834086 | ATR inhibition induces NF-κB-dependent immunogenicity in Merkel cell carcinoma independent of cGAS-STING. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/42834086 | PubMed |
| 42819236 | A spatial-microbial-metabolic-immune framework for high-risk oral potentially malignant disorders: an evidence-ranked review for malignant transformation risk stratification. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42819236 | PubMed |
| 42812989 | WWP2 in immune surveillance and antigen presentation: context-dependent roles in B cells, T cells, and tumor immune escape. | Front Immunol | 2026 | https://conductscience.org/library/papers/42812989 | PubMed |
| 42787254 | Beyond Structure: The Dynamic Role of the Extracellular Matrix Components in Immune Evasion. | Cancer Commun (Lond) | 2026 | https://conductscience.org/library/papers/42787254 | PubMed |
| 42786283 | Hepatitis B virus protein X promotes survival and loss of hepatocyte identity in a differentiated human liver organoid system. | Cell Death Differ | 2026 | https://conductscience.org/library/papers/42786283 | PubMed |
| 42781243 | Targeting the DNA Damage Response in Cancer. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42781243 | PubMed |
| 42774904 | Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8+ T cells. | Mol Ther Nucleic Acids | 2026 | https://conductscience.org/library/papers/42774904 | PubMed |
| 42774728 | Beyond histocompatibility: human leukocyte antigen as a cross-disciplinary platform for immune recognition and clinical decision-making. | Front Immunol | 2026 | https://conductscience.org/library/papers/42774728 | PubMed |
| 42761714 | Lineage plasticity and immune invisibility in primary SCLC and LUAD-to-SCLC transformation: antigen presentation loss and therapeutic redirection. | Front Immunol | 2026 | https://conductscience.org/library/papers/42761714 | PubMed |
Genes68
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33767702
GET https://conductscience.org/api/papers/v1/33767702/references?page=2